Trial intelligence / Profile preview

Inhaled Corticosteroids in Ventilated Preterm Neonates

NCT03503994Completed

Sponsor
Mount Sinai Hospital
Start
Jul 2001
Primary completion
Nov 2006
Modality
Small Molecules
01

Overview

Open-label trial of beclomethasone dipropionate in bronchopulmonary dysplasia (BPD) (4 arms), sponsored by Mount Sinai Hospital. Primary endpoints: Reduction in Fractional Oxygen Concentration of Inspired Gas > 75% at 1 week and Successful Extubation at 1 week. Started Jul 2001; status: completed.

02

Drugs

beclomethasone dipropionate
03

Conditions

bronchopulmonary dysplasia (BPD)

Beyond the preview

Go deeper on NCT03503994.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03503994.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call